DE69133321D1 - Neuartige cytokine - Google Patents

Neuartige cytokine

Info

Publication number
DE69133321D1
DE69133321D1 DE69133321T DE69133321T DE69133321D1 DE 69133321 D1 DE69133321 D1 DE 69133321D1 DE 69133321 T DE69133321 T DE 69133321T DE 69133321 T DE69133321 T DE 69133321T DE 69133321 D1 DE69133321 D1 DE 69133321D1
Authority
DE
Germany
Prior art keywords
protein
activity
adipocyte formation
result
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69133321T
Other languages
English (en)
Other versions
DE69133321T2 (de
Inventor
Ichiro Kawashima
Jun Ohsumi
Kenji Miyadai
Yo Takiguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26343378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69133321(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE69133321D1 publication Critical patent/DE69133321D1/de
Publication of DE69133321T2 publication Critical patent/DE69133321T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5431—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69133321T 1990-11-08 1991-11-07 Neuartige cytokine Revoked DE69133321T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30355890 1990-11-08
JP30355890 1990-11-08
JP878591 1991-01-29
JP878591 1991-01-29
PCT/JP1991/001526 WO1992008735A1 (en) 1990-11-08 1991-11-07 Novel cytokine

Publications (2)

Publication Number Publication Date
DE69133321D1 true DE69133321D1 (de) 2003-11-06
DE69133321T2 DE69133321T2 (de) 2004-07-29

Family

ID=26343378

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133321T Revoked DE69133321T2 (de) 1990-11-08 1991-11-07 Neuartige cytokine

Country Status (11)

Country Link
EP (1) EP0556395B1 (de)
JP (1) JP2752819B2 (de)
KR (1) KR0139095B1 (de)
AT (1) ATE250935T1 (de)
CA (1) CA2095840A1 (de)
DE (1) DE69133321T2 (de)
DK (1) DK0556395T3 (de)
ES (1) ES2206440T3 (de)
HK (1) HK1017817A1 (de)
HU (1) HU217803B (de)
WO (1) WO1992008735A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0566410A3 (en) 1992-04-17 1994-08-24 Sankyo Co Derivatives of adipogenesis inhibitory factor, their preparation and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11

Also Published As

Publication number Publication date
EP0556395B1 (de) 2003-10-01
CA2095840A1 (en) 1992-05-09
WO1992008735A1 (en) 1992-05-29
EP0556395A4 (en) 1994-08-24
ES2206440T3 (es) 2004-05-16
HK1017817A1 (en) 1999-11-26
HU9301330D0 (en) 1993-09-28
DE69133321T2 (de) 2004-07-29
ATE250935T1 (de) 2003-10-15
EP0556395A1 (de) 1993-08-25
KR930702525A (ko) 1993-09-09
HUT66624A (en) 1994-12-28
KR0139095B1 (ko) 1998-04-30
DK0556395T3 (da) 2004-02-02
JPH0592997A (ja) 1993-04-16
HU217803B (hu) 2000-04-28
JP2752819B2 (ja) 1998-05-18

Similar Documents

Publication Publication Date Title
ES8802182A1 (es) Un procedimiento para preparar una linfotoxina.
YU71395A (sh) Acilovani analozi insulina
DK0559884T3 (da) Rekombinante virusvektorer til ekspression i muskelceller
DE69018920T2 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE404668T1 (de) Wachstumsfaktor-homologe zvegf-3
DK0464105T3 (da) Melaninkoncentrerende hormoner og DNA til ekspression af samme
NO165804C (no) Veksthormon-frigjoerende peptider og anvendelse derav.
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
KR920004571A (ko) 헤파린 결합 향신경성 인자(hbnf)를 암호하는 유전자, 이를 포함하는 발현 벡터 및 숙주 세포, 및 hbnf의 생성 방법 및 사용방법
JPS6420095A (en) Polypeptide having anti-blood coagulating action
DE68917837D1 (de) Peptid-Verbindungen.
NZ336555A (en) A recombinant molecule containing the DefH9 promoter combined with a DNA sequence useful for producing parthenocarpic transgenic plants and enhancing fruit setting and development
ATE154362T1 (de) Verfahren zur herstellung von pai-2
ATE250935T1 (de) Neuartige cytokine
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
Catalano-Sherman et al. Amino acid sequence of a major human amelogenin protein employing Edman degradation and cDNA sequencing
Suzuki et al. Sea urchin protease specific to the SPKK motif in histone
Gibson et al. Human and sheep growth-plate cartilage type X collagen synthesis and the influence of tissue storage
Perez-Polo et al. The Physical and Biological Properties of 7S and β-NGF from the Mouse Submaxillary Gland
RU93033086A (ru) Белки, днк, способ получения белка, вектор, хозяйская клетка, фармацевтические композиции, способы лечения и профилактики
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
ATE360078T1 (de) Mannanase aus kaffee
EA199900339A1 (ru) Ген роста человека и область гена, ответственная за низкий рост

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation